Charging 6% higher today: What is happening with the Pro Medicus share price?

How much further could they go?

The Pro Medicus Ltd (ASX: PME) share price is storming higher in lunchtime trade on Wednesday. At the time of writing, the beaten-down stock is 6.08% higher at $114.72 a piece.

The uptick is welcome news for investors after the stock faced multiple headwinds over the past year, sending its share price crashing. For the year-to-date, Pro Medicus shares are now down 48.47% and they've shed a huge 59.54% over the year.

But it looks like the medical imaging technology stock has finally caught a break.

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.

Image source: Getty Images

Why are Pro Medicus shares climbing higher today?

There is no price-sensitive news out of the company today to explain the uplift. 

But over the past 48 hours, the company has announced in a note to the ASX that three of its directors have increased their existing stake by purchasing additional Pro Medicus shares.

It is unlikely to immediately influence the share price, but it does raise a green flag for other investors and, in turn, can boost confidence in the company's share price outlook.

What sent Pro Medius shares crashing over the past 12 months?

Pro Medicus has suffered several headwinds over the past year. The sector-wide tech sell-off and fear of AI disruptions late last year (and in early 2026) prompted many investors to flee the sector. 

At the same time, the stock rallied nearly 250% between early 2024 and mid-2025, prompting concerns that the shares were overpriced. After significant gains, it's common for investors to lock in the profits and sell up, therefore pushing the price lower.

So what's ahead for the stock this year?

Pro Medicus is a medical imaging technology provider for hospitals, imaging centres, and healthcare groups. It is a leading supplier of radiology information systems, picture archiving and communication systems, and advanced visualisation solutions for medical practices and hospitals. The ASX 200 share has offices in Australia, Germany, and the US.

It has a wide range of clients on long-term contracts too, and is continually expanding its presence worldwide. Earlier this month, the business won a new 5-year A$10 million contract with University Hospital Heidelberg (UKHD) and German Cancer Research Institute (DKFZ).

Earlier this month, it also posted its half-year results, which revealed strong financials and confirmed that it is gaining traction with long-term contracts, has strong earnings visibility, and a growing pipeline of major contract wins, all against a backdrop of radiologist shortages. 

Analysts are also incredibly bullish on Pro Medicus shares.

Out of 14 analysts, nine have a buy or strong buy rating on the stock. The average target price is $220.75, which implies a 92.71% upside at the time of writing. However, some think it could soar even higher to $300 a piece. That represents a potential 161.92% upside for Pro Medicus shares.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Processor chip on circuit board with copy space for design.
Technology Shares

Anthropic shares: A broker sees 60% upside. Here's why I would hesitate

The consensus for the share price is for more gains.

Read more »

Rising stacks of coins next to a piggy bank.
Technology Shares

Considering buying Technology One shares? Here are the ratings of 8 experts

Technology One reported more growth in FY26. Is it a buy?

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Technology Shares

3 ASX shares I'd buy if the technology sell-off gets worse

I'm watching these three shares closely, and I'd be happy to buy if their valuations become even more attractive.

Read more »

A silhouette of a soldier flying a drone at sunset.
Technology Shares

If I had $10,000 I had to lock up in one share for a decade, this would be it

This technology manufacturer ticks all the boxes for me.

Read more »

Colourful explosion symbolising ASX share price growth.
Technology Shares

This ASX tech share is surging 47% higher today. Analysts see more upside ahead

The ASX shares have now recouped losses shed earlier this year.

Read more »

A man and woman high five each while sitting down after working out at the gym.
Technology Shares

3 reasons to buy Catapult Sports shares after crashing 17% on results day

The market didn't like the latest results, but I think there's more to the story than the widening loss.

Read more »

Rocket going up above mountains, symbolising a record high.
Technology Shares

This company has almost no revenue. So why are its shares up nearly 10 times?

A collaboration with Amazon has investors interested.

Read more »

Work colleagues discussing finance charts and graphs on a laptop computer and tablet in their office.
Technology Shares

3 reasons I'd buy TechnologyOne shares after today's strong FY26 results

I've been looking through today's figures, and three things have given me more confidence in the company's growth prospects.

Read more »